Stryker Corp. closed 2.72% below its 52-week high of $406.19, which the company reached on January 28th.

A DLA contract modification awarded to Stryker exercises the five-year option period of an IDIQ contract for patient ...

Stryker received FDA 510(k) clearance for its Incompass® Total Ankle System, intended for patients with severe arthritis-related ankle joint damage.

The global Knee Replacement Surgery Market, valued at US$10.86 billion in 2023 stood at US$12.00 billion in 2025 and is ...

Hemorrhagic strokes account for just 13% of the nearly 800,000 strokes that occur in the U.S. each year, yet they are ...

One group is betting the state’s blend of libertarianism and progressivism can be packaged to appeal to voters who have ...

Explore the insights of the Biopsy Devices Companies Quadrant—a comprehensive analysis of the global biopsy device market. This report evaluates over 140 companies, highlighting the top 15 leaders ...

The global tumor ablation market is projected to surge from USD 1.67 billion in 2024 to USD 4.15 billion by 2032. Driven by advancements in minimally invasive techniques like radiofrequency and ...

IFP Advisors Inc increased their stake in Stryker Corporation by 17.3%, now holding shares valued at nearly $979,000. Other heavy hitters in the investment world have also adjusted their Stryker ...

The global Hemostats Market, valued at US$2.80 billion in 2024 stood at US$2.90 billion in 2025 and is projected to advance ...

Emily's BravoTV.com bio adds more detail about the situation, noting she "takes on one of the biggest challenges of her life when one of her sons is diagnosed with a rare medical condition." ...